These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22116469)

  • 1. Oxidative stress in phenylketonuria: future directions.
    Rocha JC; Martins MJ
    J Inherit Metab Dis; 2012 May; 35(3):381-98. PubMed ID: 22116469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Barden AT; Biancini GB; Vargas PR; de Souza CF; Netto C; Wajner M; Vargas CR
    Int J Dev Neurosci; 2009 May; 27(3):243-7. PubMed ID: 19429389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
    Bortoluzzi VT; Brust L; Preissler T; de Franceschi ID; Wannmacher CMD
    Metab Brain Dis; 2019 Dec; 34(6):1649-1660. PubMed ID: 31352540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilic antioxidants in patients with phenylketonuria.
    Colomé C; Artuch R; Vilaseca MA; Sierra C; Brandi N; Lambruschini N; Cambra FJ; Campistol J
    Am J Clin Nutr; 2003 Jan; 77(1):185-8. PubMed ID: 12499340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting specific nutrient deficiencies in protein-restricted diets: some practical facts in PKU dietary management.
    Pimentel FB; Alves RC; Oliva-Teles MT; Costa AS; Fernandes TJ; Almeida MF; Torres D; Delerue-Matos C; Oliveira MB
    Food Funct; 2014 Dec; 5(12):3151-9. PubMed ID: 25277724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.
    Martinez-Cruz F; Pozo D; Osuna C; Espinar A; Marchante C; Guerrero JM
    J Neurosci Res; 2002 Aug; 69(4):550-8. PubMed ID: 12210848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.
    Bortoluzzi VT; Dutra Filho CS; Wannmacher CMD
    Metab Brain Dis; 2021 Apr; 36(4):523-543. PubMed ID: 33580861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of antioxidant status in phenylketonuric patients.
    Artuch R; Colomé C; Sierra C; Brandi N; Lambruschini N; Campistol J; Ugarte D; Vilaseca MA
    Clin Biochem; 2004 Mar; 37(3):198-203. PubMed ID: 14972641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycomacropeptide (GMP) rescued the oxidative and inflammatory activity of free L-AAs in human Caco-2 cells: New insights that support GMP as a valid and health-promoting product for the dietary management of phenylketonuria (PKU) patients.
    Lammi C; Bollati C; Fiori L; Li J; Fanzaga M; d'Adduzio L; Tosi M; Burlina A; Zuccotti G; Verduci E
    Food Res Int; 2023 Nov; 173(Pt 1):113258. PubMed ID: 37803570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
    MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
    Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin and mineral status in patients with hyperphenylalaninemia.
    Crujeiras V; Aldámiz-Echevarría L; Dalmau J; Vitoria I; Andrade F; Roca I; Leis R; Fernandez-Marmiesse A; Couce ML
    Mol Genet Metab; 2015 Aug; 115(4):145-50. PubMed ID: 26123187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant treatment strategies for hyperphenylalaninemia.
    Mazzola PN; Karikas GA; Schulpis KH; Dutra-Filho CS
    Metab Brain Dis; 2013 Dec; 28(4):541-50. PubMed ID: 23657560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
    Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
    Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A food pyramid for adult patients with phenylketonuria and a systematic review on the current evidences regarding the optimal dietary treatment of adult patients with PKU.
    Rondanelli M; Porta F; Gasparri C; Barrile GC; Cavioni A; Mansueto F; Mazzola G; Patelli Z; Peroni G; Pirola M; Razza C; Tartara A; Perna S
    Clin Nutr; 2023 May; 42(5):732-763. PubMed ID: 37001196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge.
    Evans S; Daly A; MacDonald J; Preece MA; Santra S; Vijay S; Chakrapani A; MacDonald A
    Ann Nutr Metab; 2014; 65(1):42-8. PubMed ID: 25196394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.